Back to top
Lanolimus 0.25 mg Tablet
Lanolimus 0.25 mg Tablet

Lanolimus 0.25 mg Tablet

Lanolimus 0.25 mg Tablet Specification

  • Pacakaging (Quantity Per Box)
  • 10 tablets per box
  • Salt Composition
  • Sirolimus derivative (Lanolimus)
  • Origin of Medicine
  • Synthetic
  • Drug Type
  • Pharmaceutical Drug
  • Ingredients
  • Lanolimus
  • Physical Form
  • Tablet
  • Function
  • Immunosuppressant used to prevent organ rejection after transplantation
  • Recommended For
  • Patients undergoing organ transplantation
  • Dosage
  • 0.25 mg
  • Dosage Guidelines
  • As prescribed by a healthcare professional; typically taken orally with or without food
  • Suitable For
  • Adults
  • Quantity
  • Each package contains 10 tablets
  • Storage Instructions
  • Store in a cool dry place away from direct light and moisture
 
 

About Lanolimus 0.25 mg Tablet



Lanolimus 0.25 mg Tablet is a pharmaceutical drug containing Lanolimus as the active Sirolimus derivative ingredient. It is specially formulated for adult patients undergoing organ transplantation to prevent organ rejection. Each box contains 10 tablets of 0.25 mg dosage to be taken orally as directed by a healthcare professional. The tablets are stored in a cool, dry place away from light and moisture. Lanolimus functions as an immunosuppressant to support the bodys acceptance of new organs. This synthetic medication is available in a convenient tablet form for easy consumption.

FAQs of Lanolimus 0.25 mg Tablet:


Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Yondelis Injection

Yondelis Injection

Recommended For : Patients diagnosed with soft tissue sarcoma or ovarian cancer

Dosage : As directed by the physician

Quantity : 1 vial

Physical Form : Other, Injection

Function : Treatment of soft tissue sarcoma and ovarian cancer, Other

Dosage Guidelines : Administered intravenously under the supervision of a qualified healthcare professional

Anarzole 1 mg Tablet

Anarzole 1 mg Tablet

Recommended For : Postmenopausal women with hormone receptorpositive breast cancer

Dosage : 1 tablet daily

Quantity : 10 tablets per strip

Physical Form : Other, Tablet

Function : Other, Treatment of breast cancer in postmenopausal women

Dosage Guidelines : To be taken orally as prescribed by a healthcare professional; preferably at the same time each day

Lapahope 250 mg Tablet 120N

Lapahope 250 mg Tablet 120N

Recommended For : Patients with HER2positive breast cancer

Dosage : 250 mg per tablet

Quantity : 120 tablets per box

Physical Form : Other, Tablet

Function : Other, Used to treat breast cancer and other specific conditions

Dosage Guidelines : As directed by the physician

Neuzumab 440 mg Injection

Neuzumab 440 mg Injection

Recommended For : Patients with HER2positive cancers

Dosage : 440 mg per vial

Quantity : 1 vial per pack

Physical Form : Other, Injection

Function : Other, Treatment of HER2positive breast cancer and gastric cancer

Dosage Guidelines : Administered as an intravenous infusion under medical supervision